Carroll Financial Associates’s Illumina ILMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
$69K Sell
186
-1
-0.5% -$379 ﹤0.01% 632
2021
Q3
$73K Sell
187
-50
-21% -$23K ﹤0.01% 629
2021
Q2
$109K Buy
237
+6
+3% +$2.42K 0.01% 558
2021
Q1
$86K Buy
231
+144
+166% +$58.7K 0.01% 608
2020
Q4
$31K Buy
+87
New +$27.7K ﹤0.01% 814
2020
Q3
Sell
-89
Closed -$32K 1575
2020
Q2
$32K Buy
+89
New +$28.6K ﹤0.01% 757
2020
Q1
Sell
-604
Closed -$195K 1550
2019
Q4
$195K Buy
+604
New +$183K 0.02% 366
2019
Q2
Sell
-38
Closed -$11K 1629
2019
Q1
$11K Buy
+38
New +$11.1K ﹤0.01% 920
2016
Q1
Sell
-28
Closed -$5K 1160
2015
Q4
$5K Hold
28
﹤0.01% 864
2015
Q3
$3K Hold
28
﹤0.01% 929
2015
Q2
$6K Buy
+28
New +$5.47K ﹤0.01% 818

Other funds holding ILMN

Carroll Financial Associates's ILMN Position: Q4 2021 in Review

Carroll Financial Associates reduced its Illumina (ILMN) stake by 0.53% in Q4 2021, selling an estimated $379 and leaving 186 shares worth $69K. The position accounts for ﹤0.01% of the portfolio, ranked #632.

Carroll Financial Associates first reported a position in ILMN in Q2 2015 and has held it in 11 quarters since. The position peaked at $195K in Q4 2019. 1,067 funds tracked by Wall St. Rank hold ILMN as of Q4 2021.

  • Carroll Financial Associates held 186 shares of Illumina worth $69K as of Q4 2021.
  • Carroll Financial Associates sold 1 Illumina share in Q4 2021, an estimated $379.
  • Illumina made up ﹤0.01% of Carroll Financial Associates's portfolio in Q4 2021, its #632 holding.
  • Carroll Financial Associates first reported a position in Illumina in Q2 2015 and has held it in 11 quarters since.
  • Carroll Financial Associates's Illumina position peaked at $195K in Q4 2019.
  • 1,067 funds tracked by Wall St. Rank held Illumina as of Q4 2021.

Based on Carroll Financial Associates's 13F filing for Q4 2021, filed 6 Jan 2022.